Skip to content
2000
Volume 20, Issue 6
  • ISSN: 1573-4072
  • E-ISSN: 1875-6646

Abstract

Background: One of the most crucial heterocycles is piperazine for the creation of novel medication candidates with a variety of medicinal applications. The piperazine moiety is a cyclic compound with four carbon atoms and two nitrogen atoms in positions 1 and 4. Objective: The objective of this studty is the development of 1-((3,4-dimethoxyphenyl) (substitutedphenyl) substituted -piperazine (A-A) analogs via the one-pot synthesis method and evaluation for their preliminary antibacterial, antifungal, antimycobacterial, antioxidant, and antimalarial activity. Methods: Desired piperazine derivatives were obtained in a single step reaction using piperazine, aldehydes, and boronic acid derivatives. The structures of all newly synthesized compounds have been established based on analytical and spectral data. An molecular docking study was carried out for the series. Results: The spectral data using IR, 1H NMR, and 13C NMR and mass spectra confirmed the structure of the synthesized compounds. Compounds A and A were found to be the most promising agents for antimalarial activity. A-A showed a higher IC value and found less antioxidant activity. Some of the compounds showed higher potency when compared to the standard drugs in this antimicrobial study. Conclusion: The structure-activity study showed that changes in substituents either on aldehyde, piperazine, or boronic acid derivatives can lead to potential active compounds. These facts make the compounds interesting candidates for further evaluation of their efficacy in the treatment of microbial, tubercular and malarial diseases.

Loading

Article metrics loading...

/content/journals/cbc/10.2174/0115734072265828231010050909
2024-07-01
2025-05-28
Loading full text...

Full text loading...

/content/journals/cbc/10.2174/0115734072265828231010050909
Loading

  • Article Type:
    Research Article
Keyword(s): antimalarial; antimicrobial; antimycobacterial; antioxidant; molecular docking; Piperazine
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test